COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And ‘Strong Progress Across The Business’
Psychedelics biotech COMPASS Pathways’ (NASDAQ: CMPS) consolidated unaudited financial results for the second quarter 2023, ended June 30 are as follows: